Reliance Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 17 Nov 2017 66.76 0.64
(0.97%)

NAV High-Low (in Rs)

ONE Mth 1687.10
1687.10
52-WEEk 1235.15
1687.10

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - 1.17 2.63 - 3.57
Sensex 0.08 2.25 8.75 27.13 18.33
Nifty -0.37 0.48 7.96 27.27 21.98

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 6.50 (Rs) 27-02-2017
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Oct 2017
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 0.91
Commercial Paper 1.47
Derivatives 0.85
Equity 96.77
Net CA & Others 0.01
› More
   As On 31 Oct 2017
Sector Name Amount
Finance & Investments 2.29
Healthcare 12.40
NA 3.24
Pharmaceuticals - Indian - Bulk Drugs 15.64
Pharmaceuticals - Indian - Bulk Drugs & Formln 50.84
Pharmaceuticals - Multinational 15.60
› More
   As On 31 Oct 2017
Company Name
Divi's Lab. 10.46
Dr Reddy's Labs 9.66
Sun Pharma.Inds. 9.51
Cipla 9.12
Aurobindo Pharma 8.11
Abbott India 8.04
Sanofi India 7.56
Thyrocare Tech. 6.71
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com